Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study

Maria Di Bartolomeo, Andrea Ciarlo, Alessandro Bertolini, Sandro Barni, Claudio Verusio, Enrico Aitini, Filippo Pietrantonio, Roberto Iacovelli, Katia Fiorella Dotti, Claudia Maggi, Federica Perrone, Emilio Bajetta

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences